Insmed Inc. buy Raymond James
Start price
10.04.26
/
50%
€133.40
Target price
10.04.27
€171.08
Performance (%)
-38.69%
Price
05.06.26
€89.19
Summary
This prediction is currently active. The BUY prediction by Raymond_James for Insmed Inc. is performing very badly with a performance of -38.69%. This prediction currently runs until 10.04.27. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -2.439% | -2.439% |
| iShares Core DAX® | -1,86 % | 0,67 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % |
| iShares S&P 500 | -1,31 % | 3,40 % |
Comments by Raymond_James for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) is now covered by Raymond James Financial, Inc.. They set an "outperform" rating and a $200.00 price target on the stock.
Ratings data for INSM provided by MarketBeat